(19)
(11) EP 1 646 401 A2

(12)

(88) Date of publication A3:
16.02.2006

(43) Date of publication:
19.04.2006 Bulletin 2006/16

(21) Application number: 04777349.4

(22) Date of filing: 30.06.2004
(51) International Patent Classification (IPC): 
A61K 39/395(1985.01)
(86) International application number:
PCT/US2004/021099
(87) International publication number:
WO 2005/005455 (20.01.2005 Gazette 2005/03)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 30.06.2003 US 610840

(71) Applicant: Bio-Technology General (Israel) Ltd.
Rehovot 76326 (IL)

(72) Inventors:
  • LEVANON, Avigdor
    Revohot (IL)
  • VOGEL, Tikva
    Rehovot (IL)
  • PLAKSIN, Daniel
    Rehovot (IL)
  • PERETZ, Tuvia
    Hod Hasharon (IL)
  • AMIT, Boaz
    Kiron (IL)
  • COOPERMAN, Lena
    Rishon Lezion (IL)
  • HAGAY, Yocheved
    Rehovot (IL)
  • SZANTON, Esther
    Rehovot (IL)
  • KANFI, Yariv
    Pethch Tikva (IL)
  • BEN-LEVY, Rachel
    Re'em (IL)
  • SZRAJBER, Tali
    Hadar Ganim Petach-Tikva (IL)

(74) Representative: Furlong, Isla Jane et al
D Young & Co 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) SPECIFIC HUMAN ANTIBODIES